Emerging Medication in Australia: A Potential Hope for Weight Loss ?
Australia is closely watching the arrival of retatrutide, a innovative dual GIP and GLP-1 receptor medication , representing a potential advance in addressing excess weight. Early study data have demonstrated impressive results, showing greater impact than existing treatments like semaglutide. Wh